Ronald Moss, M.D. has served as the Chief Executive Officer of Ansun Biopharma, Inc. since October 2012, and before that, served as both interim CEO and Executive Vice President of Clinical Development and Medical Affairs at Ansun from 2008 to 2012. Dr. Moss has held various executive positions in the pharmaceutical industry for over 20 years and has played a pivotal role in successfully leading companies through the complexities of drug and vaccine development. Dr. Moss has been involved in drug and vaccine development of products in Infectious Disease, Allergy, Neurology, Dermatology, Oncology, Respiratory, Transplant, and Autoimmunity in both large pharmaceutical and biotechnology companies, including roles at Aventis, Immune Response, Merck, Telos and Vical. He has also authored over 70 scientific publications. Prior to joining industry, he received his M.D. degree from Chicago Medical School, completed a residency in pediatrics at SUNY Stony Brook and completed a fellowship at the National Institutes of Health. He is double boarded in Pediatrics and Allergy and Immunology. He is also a Fellow of the American Academy and American College of Allergy and Immunology

Infectious Disease, Allergy, Neurology, Dermatology, Oncology, Respiratory, Transplant, and Autoimmunity.

Dr. Chen currently is the Deputy Director of Alaska State Public Health Virology Laboratory and an Associate Professor in the Department of Biology and Wildlife and Institute of Arctic Biology at the University of Alaska Fairbanks. Dr. Chen's research activity focuses on the diagnosis and research of public health related viral infection in Alaska. His Virology Laboratory is a joint effort between State of Alaska Public Health Division and University of Alaska Fairbanks. Current research projects involve both clinical and basic virology research. Dr.Chen obtained his Ph.D. Degree in Virology at Osaka University Medical School in Japan and his post doctorate training at University of British Columbia at Vancouver, Canada.

The clinical research focuses on molecular diagnosis of viral infections, as well as technology development for the diagnosis of emerging human pathogens. The basic research in this lab involves in the virus-human cell interaction and the role of tumor virus in human tumorigenesis.

Girish J. Kotwal, received his Ph.D. from the Biochemistry department, McMaster University, Canada in 1985. He did his post doctoral work at the National Institutes of Health (NIH) in Bethesda, MD, USA in the Laboratory of Viral Diseases from 1984-1990 and co-discovered the vaccinia virus complement control protein (VCP) along with Dr. Bernard Moss, member of the US National Academy of Science (NAS). During the 90s he established a structural biology program which included overexpression of VCP, a heavily disulphide bonded protein and directed the preclinical program to evaluate the therapeutic potential of VCP. In 2002 he founded Kotwal Bioconsulting, LLC, in 2004 he founded kbiotech pvt. ltd., in South Africa, in 2005 he co-founded InFlaMed Inc. in USA. In 2010 he assisted in founding Icelandic Cardio Pharma (IceCP) in Iceland. He is currently Professor of Biochemistry and Microbiology at UMHS, WI, Adjunct Professor of Medicine, UMass medical school, Worcester, MA and Adjunct Professor of Traditional Chinese Medicine at Henan University, China. He has authored over 100 publications, 97 of which are found on pubmed.

Medical Microbiology, Dental Microbiology and Immunology, Cellular and Molecular Immunology, Intracellular signaling mechanisms in lymphoid cell activation, Cytolytic mechanisms of CTLs and NK cells, Complement pathways & complement regulatory proteins, Immune responses against tumors, Mechanisms of apoptosis in the immune system, transgenic and knockout mice, Modern vaccine design & immunization, HLA & TCR genes in autoimmunity, cellular and molecular mechanisms of autoimmunity, Fundamental Virology, Molecular Virology,

C. Yong Kang has completed his PhD from McMaster University in Canada and post-doctoral training at the University of Wisconsin-Madison. He served as a Professor of Virology at the University of Texas Southwestern Medical School, Professor and Chairman at the University of Ottawa Faculty of Medicine, and Dean of Science at the University of Western Ontario. He has published 137 peer reviewed research papers and 151 scientific proceedings and abstracts. He holds nine international biotechnology patents. He received numerous awards including the Ho-Am Prize in Medicine. He is a Life-time Fellow of the Royal Society of Canada Academy of Science. He serves as a reviewer for eight international journals.

Professor Jun-Wen Li, doctoral supervisor at institute of Health and Environmental Medicine, is the academic leader of environmental hygiene. He was appointed as a visiting scholar to the Water Research Centre, University of New South Wales in the Australia (2006.9-2007.9) because of his outstanding work. His research has been supported by more than 20 foundation-programs. He has published more than 20 papers in reputed journals and has been serving as an editorial board member of many journals.

His major interests are microorganisms detection technology in water and food, disinfection of drinking water and safety evaluation for recycle water.

Dr. Yefei Zhu, is the Deputy Chief and Team Leader for the outbreak response team in the Department of Acute Infectious Diseases Outbreak Response and Prevention, Jiangsu Provincial Center for Disease Control and Prevention in China. During his 8 years with the Jiangsu CDC, He received his M.D. degree from Nanjing Medical University, Nanjing, China in 2006. He was certified as professor Jiangsu Province Science and Technology Department, Nanjing, China in 2014. His research interests draw on the interplay between epidemiology and public health. His research has focused on the epidemiology of infectious diseases, with recent emphasis on molecular and geographic applications in Jiangsu, China. His research involves extensive collaboration with colleagues from other disciplines, including microbiology, geography, public health, climate change, et al.

Dr.Zhu focused his efforts on investigating outbreaks of human illnesses caused by pathogens, including E coli O157:H7, norovirus, avian influenza (H7N9) virus, et al.

Dharam V. Ablashi is a microbiologist. He has published over 300 articles on herpesviruses and HIV. His major interests are assessing pathogenic roles of viruses in diseases, and in developing antivirals as therapeutic reagents. He has a BSc, and a D.M.V from Panjab University India, a Dip. Bact from I.V.R.I, and MS in Virology from the University of R.I., USA. He worked 23 years at NIH. In 1986, he co-discovered human herpesvirus-6 (HHV-6), a highly neurotropic and immune suppressive virus. He was as an adjunct professor at Georgetown University School of Medicine, Washington, DC, and Director of Herpesvirus Research in a diagnostic company. Currently, the Scientific Director of the HHV-6 Foundation, and the Senior Technology Adviser at KHG fiteBac Technology in Marietta, Georgia.

Research on herpesviruses and HIV.

Dr. Narasaiah Kolliputi is an Associate Professor and Division Director of Research Education for Division of Allergy and Immunology at the Morsani College of Medicine. Kolliputi is working on translational strategies to attenuate oxidative stress mediated acute lung injury (ALI) and pulmonary fibrosis. He received his postdoctoral training in the Massachusetts General Hospital, Harvard Medical School. Kolliputi is currently serving as a grant reviewer for the National Institute of Health, Department of Defense and American Heart Association Grants. He is an Associate Editor for Frontiers in Pharmacology, Frontiers in Physiology, Frontiers in Genetics and Guest Associate Editor for Frontiers in Mitochondrial Physiology, Editorial Board Member for Translational Medicine, Virology & Mycology and Journal of Biocatalysis & Biotransformation. Dr. Kolliputi’s research is funded by NIH RO1 and American Heart Association Scientist Developmental grants.

Pathogen-Associated Molecular Patterns (PAMPs) and Danger-Associated Molecular Patterns (DAMPs); Viral and fungal infections of the lung; pulmonary hemorrhage syndrome associated with dengue fever; and Lung injury.

Dr. Barakat is an Assistant Professor at the school of Pharmacy at the University of Alberta, Canada. His research stands at the multidisciplinary interface of physics, biology and computer science. Dr. Barakat has made great contributions in understanding the nature and biophysical processes underlying protein–drug, protein–protein and drug off-target interactions and predicting drug-mediated toxicity. He also received numerous awards including the CIHR and AIHS postdoctoral fellowships, the prestigious University of Alberta dissertation award and many distinction awards throughout his undergraduate and graduate studies. Dr. Barakat is also the editor of the Journal of Pharmaceutical Care & Health Systems and serves as a guest reviewer for several journals.

Dr. Barakat’s major focus is on developing and applying state-of-the-art computational drug discovery tools to discover new antiviral and immunotherapeutic drugs.

Dr Nguyen Van Bang finished his PhD in Amiens University, France in 2005 and has awarded Associate Professor in 2009 and becomes Executive Member of Vietnam Pediatric Association and Vice-President of Vietnam Pediatric Digestive Association since 2010. He is director of an international scientific project (origin of the proposed communication), of 2 national and 3 ministerial ones and numerous hospital and community based studies. He has published more than 100 scientific papers in reputed international and national journals in medicine and healthcare (5 in French, 7 in English and more than 90 in Vietnam). He has presented more than 20 communications in world and international congresses.

Medicine and Healthcare

Dr. Patricia Araujo received her Ph.D. from the University of Cambridge (UK) and was a post-doctoral fellow in the Molecular Virology Department at the Federal São Paulo University (Brasil).

She is now an Chief of Virology and Serologic screen laboratories at the Blood Bank- Colsan of Federal São Paulo University.She has a long standing interest in the molecular biololgy of hepatitis B virus, mechanisms of virus replication and virus host cells interactions that result in innate immune responses to infection.

Dr Massimo Cecaro after completing the high school in humanistic studies, he moved to the University of Camerino, where he got a Master Degree in Veterinary Medicine and in University of Teramo he successfully got the Specialization. Since the age of 14, he has worked as radio speaker, tv presenter and reporter for a wide range of artistic and scientific events. At the age of 24 he obtained a qualification to practice as a Journalist and in 2007 he was admitted to the National Association of Medical Press (ASMI), where he currently hold the position of National Councilor. He is Resident Member of MJA Medical Journalists’ Association (London). He is Member of EFSA's Expert Database. He has been an invited speaker,mentor and chairman at International events in the field of Public Health and Safety in Canada, US, Europe and Asia. He has been author of several scientific works in public health. He is also director in Italy of a prestigious Educational Centre for work safety and public health. He is actively involved in international projects to improve the role of mass-media in medical sciences, and awarded in Philadelphia, Valencia and Las Vegas with International special recognition. He is serving as an editorial member of several reputed journals like: “Journal Food Processing Technology”, “Journal of Veterinary Science & Technology”, and Editor in Chief in the “Occupational Medicine & Health Affairs” and in “Journal of Mass Communication”. He is Reviewer for "Journal od Cancer Science & Therapy”. He is Organizing Commette Member of several International Conferences in US and in Europe

• Medical and scientific communication • Risk analysis • Epidemiology • Work safety • Food safety • Nutritional Science • Anthropozoonoses • Comparative oncology

Paul B.Fisher is Professor & Chairman, Department of Human and Molecular Genetics and Director, VCU Institute of molecular Medicine, Virginia Commonwealth University School Of medicine ,Richmond , Virginia, Research focuses on three broad areas; cancer, neurodegeneration & infectious diseases. A primary aim is to move discoveries made in the laboratory into the clinic, the concept of “bench-to-bedside”. He is among the top 5% of NIH funded investigators over the past 25 years, published over 400 primary papers and review articles, serves on many US government and private review panels and has over 55 issued US and numerous international patents.

Innovative approaches to discovery and molecular characterization of genes involved in susceptibility to cancer, neurodegeneration and infectious diseases.

Dr. Babita Agrawal is a professor in the Department of Surgery, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. She completed M.Sc. (1987) in biochemistry and PhD (1993) in Immunology. After completing post-doctoral work, she joined a major Canadian biotech company in 1996 where she received outstanding R & D achievement awards for consecutive years and rose to the position of Manager and Head of Immunology Research. She headed a large group of scientists, focusing on basic to translational research on novel immunotherapy and vaccine technologies, leading to clinical trials. In 2001, she joined the University of Alberta as an assistant professor and received a Medical Scholar Award in 2002 from the Alberta Heritage Foundation for Medical Research (AHFMR). In 2007, she was promoted to the rank of associate professor with tenure. In the same year she obtained a Senior Scholar Award from the Alberta Innovates Health Solutions (AIHS). In 2011, she was honored by Dean’s Award in the Faculty of Medicine and Dentistry, U of Alberta. In 2013, she was promoted to full professor. She is an established investigator with proven leadership in immunotherapy and vaccine research. In addition to a number of provincial and national grant committees, she has served as an external scientific expert in cellular immunology and vaccine research on NIH and NCI, U.S.A., grant panels and site visits.

Her research focuses on studying immune regulation and innate and adaptive immune responses, and novel small molecule inhibitors against viral infections and cancer, in order to design and study novel vaccine, immuno- and chemo-therapeutic strategies. She has published several pioneering papers in the field and has a number of issued patents. Recently, she has co-founded a small biotech based on her research in the areas of vaccine and therapeutics.

Dr.A.K.Prasad is the currently working as President of Indian Virological Society.He is also the chairman of Influenza Foundation of India.He was elected Fellow of the Geriatric Society of India (FGSI) 2014 at their Nagpur Convention (8-9 November, 2014).He has also Published over 60 Research Papers in national & International Journals & 3 Books (Chapter on Influenza).He has also received Life Time Achievement Award conferred by the Geriatric Society of India on 06th November, 2014 at the Vaccine Advocacy for the S E Asian Countries held at Delhi.

Influenza Research

Dr Atmaram Bandivdekar completed his Ph D Degree at the age of 31 years from Mumbai University. Bandivdekar was the Post-Doctoral and Carrier fellow at Population Council, New York. He was also the visiting scientist at UC Davis Primate Center. He is the Deputy Director of National Institute for Research in Reproductive Health which is the premier Institute in India in the field of Reproductive Health Research. He has published more than 70 papers in peer reviewed journals and also the book and two conference proceedings. He also has six National and International awards for his scientific contributions. Bandivdekar is actively involved research on understanding sexual transmission of HIV and development of preventive and therapeutic vaccine and formulation for prevention of HIV transmission.

Research on Viruses.

Dr. Hemida received his Ph.D from University of Guelph, 2009. He pursued his PDF training at the the University of British Columbia (James Hogg iCapture Centre). His research area of interest is “One Health Concept” with special emphasis on emerging viruses/host interaction. Currently, studying the molecular evolution and pathogenesis of MERSCoV in the Middle East. He published more than 40 original Research papers on high impacted journals. Meanwhile, he received several Research grants, prestigious honors and scholarship throughout his academic carrier. Currently, he is a reviewer of many granting agencies as well as editorial board member of many international journals.

Research interest on MERS.

Dr Benani is a responsible of Molecular Biology Laboratory at Pasteur Institute of Morocco this laboratory is a national reference laboratory for Hepatitis C Program (Moroccan ministry of health). He is also the elect-president of Arab Society for Virology and Active member on the Advisory Board, Consultative Meeting on Regional Strategy for Prevention and Control of Viral Hepatitis and Other Epidemics-Prone Blood-Borne Diseases, in 2008 (WHO/EMRO, Cairo, Egypt). He got his master of molecular biology and biotechnology at Université Libre of Bruxelles (ULB, Belgium) and his PhD in molecular microbiology in Fes University (Morocco). He participates in several international and national workshops and congresses. He is also implicated in student’s research for their training, master, and PhD. He published in several journals including journal of medical virology, BMC public health, Virology Journal, He is an active researcher in molecular epidemiology of HBV and HCV in general population and high Risk groups in Morocco. He organized the 1st International Symposium for Virology in Morocco in 2003 (Marrakech, Morocco) and the First PCR Forum and Molecular Typing at Pasteur Institute of Morocco

Molecular epidemiology of HBV and HCV

Professor Ting-Chao Chou received MS degree in Pharmacology from National Taiwan University College of Medicine; Ph.D. from Yale University, and Postdoctoral Fellowship at Johns Hopkins University School of Medicine. Joined Memorial Sloan-Kettering Cancer Center (MSKCC), became Member 1988-96, and a Professor of Pharmacology at Cornell University Graduate School of Medical Sciences, 1988-2000. He is Honorary Professor at Chinese Academy of Medical Sciences, Beijing and five other universities. He focused in the new drug discovery as the Director of Preclinical Pharmacology Core at MSKCC, where he retired on June1, 2013. His 273 scientific articles have been cited by 15,606 papers (as of 8.31.2014). (Thomson Reuters Web of Science: www.researcherid.com/rid/B-4111-2009). Prof. Chou introduced the “Unified Theory of the Median-Effect Equation of the Mass-Action Law”, and with Prof. Paul Talalay (JHU) in 1984, created the “Combination Index Theorem” for multiple entity dynamics. For one article alone (Chou TC and Talalay P., Adv Enz Regul 22:27-55, 1984), cited by 3,218 articles published in 599 biomedical journals and has become one of four the most broadly cited theoretical articles by journals of all time. Chou's dynamics equations and theory has been extended to illustrate the ancient Chinese philosophy and to advocate Econo-Green Bio-Research. He is Inventor/Co-inventor of 36 U.S. Patents, on Editorial Board of five international scientific journals, and is the founder of PD Science, LLC.

Virology

Sevgi Ciftci is the Associate Professor at the the Department of Microbiology, Faculty of Dentistry, Istanbul University, Turkey. Dr. Sevgi Ciftci obtained her BA in department of the medical biological sciences in Faculty of Medicine from the Dokuz Eylül University at Izmir- Turkey, and her PhD in Microbiology from the Medical Faculty of Istanbul University at Istanbul, in 2003.

Virology

Robin J Green is Director of Paediatric Services and Paediatric Pulmonology, Paediatric Intensive Care and Allergy Services at the Steve Biko Academic Hospital, Pretoria. He is a Full Professor in the Department of Paediatrics and Child Health within the School of Medicine at the University of Pretoria. He holds a PhD and DSc, and is a fellow of the Royal College of Physicians and Past President of the College of Paediatricians of South Africa. He is also Immediate Past Chairman of the Allergy Society of South Africa. The National Research Foundation rates him as an established researcher, in paediatric pulmonology.

Paediatrics and Child Health